SecBot SecBot
8-K ·Filed May 4, 2026

GKOS

GLAUKOS Corp
NEUTRAL
Impact 2/10
Horizonmonths Processed6mo ago SEC0001193125-26-202466
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

The filing contains no unexpected material information; traders should focus on upcoming quarterly earnings reports to assess execution against the $627.5M guidance midpoint.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$135.85
T+0 close · May 4, 2026 · via day close
Latest settled
+19.00%
T+60 · $161.66
Vs SPY
+17.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 4 $135.85entry
  2. T+1 · 7mo ago −1.79%α −2.58% · $133.42
  3. T+5 · 6mo ago −0.35%α −3.29% · $135.37
  4. T+20 · 6mo ago −24.09%α −29.74% · $103.12
  5. T+60 · 4mo ago +19.00%α +17.14% · $161.66

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Glaukos Corp filed an 8-K attaching its May 2026 investor presentation, which reiterates financial highlights including 2025 net sales of $507M, 2026 revenue guidance midpoint of $627.5M, 84% gross margin, $281M cash with no debt, and a 10-year revenue CAGR of 20%. The presentation is a standard corporate update with no material new disclosures, so the filing is routine and non-eventful.

Key Facts

  • 2025 net sales: $507 million (up from $383M in 2024)
  • 2026 revenue guidance midpoint: $627.5 million
  • Gross margin (1Q 2026): 84%
  • Cash and equivalents: $281 million; no debt as of 3/31/2026
  • 10-year revenue CAGR: 20%
  • R&D investment since 2018: $800 million

Financial Impact

No new financial impact; previously disclosed guidance and results reaffirmed.

revenuegross margincash

Risk Factors

  • Pipeline execution and regulatory approvals (e.g., iDose TRIO, Epioxa adoption)
  • Competitive pressures in interventional glaucoma and keratoconus markets

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-202466
Document: d135093d8k.htm0001193125-26-202466
Document: 0001193125-26-202466-index-headers.html0001193125-26-202466
Document: 0001193125-26-202466-index.html0001193125-26-202466
Document: 0001193125-26-202466.txt0001193125-26-202466

Track record

16 reports on GKOS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
  2. Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
  3. Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
  5. Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
  6. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
  7. Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
  8. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
  9. Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026